Penumbra

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.

About PEN

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. 

CEO
Adam Elsesser
CEOAdam Elsesser
Employees
4,700
Employees4,700
Headquarters
Alameda, California
HeadquartersAlameda, California
Founded
2004
Founded2004
Employees
4,700
Employees4,700

PEN Key Statistics

Market cap
12.69B
Market cap12.69B
Price-Earnings ratio
74.27
Price-Earnings ratio74.27
Dividend yield
Dividend yield
Average volume
406.18K
Average volume406.18K
High today
$323.28
High today$323.28
Low today
$321.39
Low today$321.39
Open price
$322.00
Open price$322.00
Volume
264.39K
Volume264.39K
52 Week high
$362.41
52 Week high$362.41
52 Week low
$221.26
52 Week low$221.26

Stock Snapshot

The current Penumbra(PEN) stock price is $322.59, with a market capitalization of 12.69B. The stock trades at a price-to-earnings (P/E) ratio of 74.27.

As of 2026-05-14, Penumbra(PEN) stock has fluctuated between $321.39 and $323.28. The current price stands at $322.59, placing the stock +0.4% above today's low and -0.2% off the high.

Penumbra(PEN) shares are trading with a volume of 264.39K, against a daily average of 406.18K.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

In the last year, Penumbra(PEN) shares hit a 52-week high of $362.41 and a 52-week low of $221.26.

PEN News

Simply Wall St 4d
Assessing Penumbra Valuation As Trial Hopes Contrast With A High Earnings Multiple

Advertisement Recent performance snapshot Penumbra (PEN) has drawn investor attention after recent trading, with the stock last closing at US$324.65. Short te...

Assessing Penumbra Valuation As Trial Hopes Contrast With A High Earnings Multiple
TipRanks 7d
Penumbra Shareholders Approve Merger with Boston Scientific

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

82%

of 11 ratings
Buy
9.1%
Hold
81.8%
Sell
9.1%

People also own

Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.